Learning Lounge:
Antibiotic resistant bacteria in our Integrated Healthcare Network: are new diagnostic tests needed? (Not Official IDWeek Programming - This activity is supported by OpGen, Inc. - See Affilaited Events Guide)
Saturday, October 29, 2016: 1:15 PM-2:00 PM
Room: IDExpo Hall H, Learning Lounge 1 ( Booth 1300)

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the official program IDWeek 2016 are independently organized and executed.  IDWeek does not endorse or support the programming of any Symposia, Presentation Theater, or Learning Lounge.

Bert K. Lopansri, MD 

Associate Professor of Medicine, University of Utah 

Chief of Infectious Diseases, Intermountain Healthcare 

Medical Director, Urban Central Region Microbiology Lab

Division of Infectious Diseases and Epidemiology  

Learning Lounge Summary: 

Multidrug resistant bacterial (MDRO) and Clostridium difficile infections are threats to patient safety. Our eight-year study describes the burden of MDROs and Clostridium difficile and depicts changing trends over time in an integrated healthcare network. We will also describe the potential impact of new diagnostics to address the clinical challenges of MDROs and Clostridium difficile infections. 

Target Audience: Infectious diseases physicians

1:15 PM
1:20 PM
Background and Methods
1:30 PM
Results and Conclusions
1:40 PM
Impact of New Diagnostic Methods

CME Credits: Maximum of 0.75 hours of AMA PRA Category 1 Credit™

ACPE Credits:

ACPE Number:

See more of: Learning Lounge

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.